CSL PHARMA-ADVICE ApS: Financial statements 2018
CVR: 36501693
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 399,613 and a net result of DKK 214,343 compared with DKK 261,918 the year before. That is a decrease of 1.1% compared with the year before. The profit margin was 53.6%. Equity in the 2018 report amounted to DKK 545,620. The solvency ratio was 92.5%.
- Revenue
- DKK 399,613
- Gross Profit
- DKK 280,541
- Profit/Loss
- DKK 214,343
- Equity
- DKK 545,620
- Total Assets
- DKK 589,606
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 400 t. | 281 t. | 214 t. | 546 t. | - |
| 2017 | 404 t. | 337 t. | 262 t. | 571 t. | - |
| 2016 | 249 t. | 189 t. | 145 t. | 309 t. | - |
| 2015 | 155 t. | 151 t. | 114 t. | 164 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CSL PHARMA-ADVICE ApS has published its annual report for 2017. Revenue came to DKK 404,000, and the net result was DKK 261,918.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.